The recent action by the Jammu and Kashmir Drugs and Food Control Organisation, leading to the suspension of licences of nine drug dealers, has once again brought the rampant misuse of pharmaceuticals into sharp focus. The special drive was aimed at curbing the illegal trade of habit-forming drugs—an issue that has quietly been taking root, especially among the youth.
What makes the revelations more alarming is the fact that wholesale dealers were found procuring pharmaceutical preparations containing Pregabalin—a drug with known abuse potential—directly from suppliers based outside J&K, bypassing all legal and regulatory frameworks. The absence of proper sales records, as mandated under the Drugs & Cosmetics Act, 1940, only adds to the gravity of the matter. It is not just a matter of regulatory violation; it is a direct threat to public health and societal well-being.
Stocks over lakhs of rupees, containing habit-forming ingredients, were seized—underscoring the scale at which this illicit trade is flourishing under the radar. The fact that some of these drugs belong to lesser-known brands further points to a well-organised network that is exploiting regulatory loopholes for profit, with little regard for the consequences.
State Drugs Controller’s stern warning against procuring such formulations without proper authorisation is both timely and necessary. The government’s declared zero-tolerance policy must now be translated into visible action—not only by way of suspensions, but also through prosecution and long-term cancellation of licences of repeat offenders.
This incident must serve as a wake-up call—not just for the authorities, but also for society at large. There is a dire need for stronger vigilance at the grassroots level. Chemists and drug distributors must be sensitised and made accountable through regular audits, digital record-keeping, and training sessions on controlled substances.
Moreover, the role of external suppliers in pushing these dangerous substances into Jammu and Kashmir cannot be ignored. Regulatory bodies across states need to work in close coordination to dismantle such networks operating beyond J&K’s borders.
In a region already grappling with the ill effects of drug addiction, the misuse of prescription medicines adds another dangerous layer to the problem. The time has come for a concerted effort involving enforcement agencies, healthcare professionals, civil society, and the public at large to ensure that our pharmacies do not become silent conduits of addiction. The message should be clear—such violations will not be tolerated, and those responsible will face the full weight of the law.
